Prostate cancer Board decisions

The Board remanded the claims for service connection for prostate cancer and bladder cancer. The Veteran's exposure to herbicides at Fort Knox during his service will be investigated.

The appeal for prostate cancer was dismissed because it was already granted. The veteran's rating for a left foot disorder was restored to 20%. The appeals for higher ratings for the left foot and knee disorders were remanded.

The Veteran's claim for a higher rating for prostate cancer residuals was denied, and the reduction from 100% to 40% effective October 1, 2018 is upheld.

The Veteran's claim for service connection for prostate cancer due to exposure to herbicide agents has been granted.,The Veteran's claim for service connection for squamous cell carcinoma (SCC) due to participation in a toxic-related exposure activity (TERA) is remanded.

The Board denied the veteran's request for a rating higher than 40% for prostate cancer. The evidence did not show that the veteran's symptoms required changing absorbent materials more than four times a day.

The Board denied the Veteran's request for an earlier effective date prior to October 22, 2021, for service connection of prostate cancer.

The appeal regarding the reduction of the prostate cancer rating was dismissed. The claim for service connection for an eye disability, including glaucoma, was reopened but ultimately denied. Claims for service connection for shakes/tremors and soft tissue sarcomas were also denied.

The Board remanded the veteran's claims for service connection of diabetes mellitus, prostate cancer, and hypertension. The veteran will receive a VA examination to determine if these conditions are related to his military service.

The veteran's appeal for a permanent and total rating for service-connected prostate cancer was granted. The condition is considered permanently incapacitating.

The Veteran's appeal for service connection of prostate cancer was granted. The Board found that the Veteran's prostate cancer is due, at least in part, to exposure to fuel during his military service.

The Board denied service connection for diabetes mellitus, type II, prostate cancer, erectile dysfunction, and diabetic peripheral neuropathy in all extremities due to lack of evidence linking these conditions to the veteran's service.

The veteran's appeal for a total disability rating based on individual unemployability (TDIU) due to service-connected disabilities was granted. The decision is based on the veteran's significant functional impairment and inability to maintain a substantially gainful occupation.

The appeal for service connection of prostate cancer was dismissed because the veteran withdrew it to pursue a supplemental claim.

The veteran's service-connected PTSD and prostate cancer residuals prevent him from obtaining or maintaining gainful employment, so he is granted total disability on individual unemployability (TDIU) effective December 30, 2022.

The Board granted an earlier effective date of January 1, 2009 for the veteran's Dependency and Indemnity Compensation (DIC) benefits. The decision was based on the veteran's presumed exposure to herbicide agents during service in Vietnam and the subsequent inclusion of bladder cancer as a presumptive disease.

The appeal for service connection of prostate cancer is remanded to correct errors in the duty to assist and to obtain a proper medical opinion.

The veteran's service-connected PTSD and prostate cancer residuals prevent him from obtaining or maintaining gainful employment, so he is granted total disability on individual unemployability (TDIU) effective December 30, 2022.

The veteran's request for a higher rating for ACD was denied, but they were granted TDIU and DEA benefits.

Service connection for both tonsil cancer and prostate cancer has been granted based on the Veteran's in-service asbestos exposure.

Service connection for prostate cancer is granted under the PACT Act. The issue of service connection on a basis other than the PACT Act is remanded.